Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1186 | Obesity | ICEECE2012

Insulin resistance and acne: a new risk factor for men?

Del Prete M. , Faggiano A. , Mauriello M. , Di Somma C. , Monfrecola G. , Fabbrocini G. , Colao A.

Introduction: Acne is a common skin disease that occasionally can be influenced by endocrine abnormalities. In females, a clear relationship has been highlight between acne onset and peripheral insulin resistance and hyperinsulinemia, whereas few data are available in male. The aim of this study was to investigate the relationship between acne and insulin resistance as well as other metabolic impairment in male subjects with acne.Methods/design: Twenty-t...

ea0029p1369 | Pituitary Clinical | ICEECE2012

Pregnancy outcomes following cabergoline treatment in hyperprolactinemic patients: an observational survey study

Auriemma R. , Grasso L. , Di Sarno A. , Perone Y. , Pivonello R. , Colao A.

Cabergoline (CAB) and other dopamine agonists are usually discontinued shortly after hyperprolactinemic patients become pregnant. Data on maternal and foetal exposure to CAB and on recurrence of hyperprolactinemia after pregnancy are still limited. The current survey study aimed at elucidating the safety of exposure to CAB during early pregnancy and the recurrence rate of hyperprolactinemia after pregnancy. Thus, 68 pregnancies in a cohort of 59 patients with hyperprolactinemi...

ea0029p1509 | Pituitary Clinical | ICEECE2012

Efficacy of testerone 2% gel replacement therapy on erectile function, muscle strenght and general wellbeing in men affected by normo-hypogonadotropic hypogonadism

Lo Calzo F. , Galdiero M. , Vitale P. , Cariati F. , Cozzolino A. , Grasso L. , Colao A. , Pivonello R.

Background: Hypogonadism is a clinical entity characterized by low serum testosterone (T) levels associated with several clinical signs and symptoms which can negatively affect the quality of life. T replacement therapy (TRT), restoring serum T concentrations, improves signs and symptoms related to hypogonadism. Many T formulations are presently available. The aim of the study was to assess effects of 2% gel TRT on serum T concentrations, erectile function, muscle strength and...

ea0026p22 | Adrenal cortex | ECE2011

Cardiac structure and function in patients with adrenal incidentaloma with and without subclinical Cushing’s syndrome

De Leo M , Galderisi M , Cozzolino A , Simeoli C , Vitale P , Raia R , Colao A , Pivonello R

Hypercortisolism has been reported to affect cardiac structure and performance. Subclinical Cushing’s syndrome (SCS) is increasingly being reported in incidentally discovered adrenal tumors; its hallmark is a mild autonomous cortisol hypersecretion without specific clinical syndrome of glucocorticoid excess. The aim of this study was to compare cardiac structure and function in patients with adrenal incidentaloma. Thirty patients (10 men, 15 women, 32–74 years) and 3...

ea0026p26 | Adrenal cortex | ECE2011

Predictive value of acute cortisol response to cabergoline administration on the responsiveness of cortisol secretion to short and long term treatment with cabergoline

Vitale P , Cozzolino A , De Leo M , Simeoli C , Galdiero M , Lombardi G , Colao A , Pivonello R

Cabergoline (CAB), a potent dopamine agonist, is one of the most effective neuromodulatory drug in the second line treatment of patients with Cushing’s disease (CD). The aim of the current study was to estimate the predictive value of the acute CAB administration on short and long term responsiveness to CAB treatment. Twenty CD patients (6 males, 14 females, 12–60 years) entered the study. The acute CAB test was performed evaluating serum cortisol every hour for 6 h ...

ea0026p32 | Adrenal cortex | ECE2011

Mission study: an international observational study on the mortality in Cushing’s syndrome

Pivonello R , Melnichenko G , Zacharieva S , Gu F , Oscar B , Shah N S , Gaillard R , Colao A

Cushing’s syndrome (CS) is a rare but severe disease associated with an increased mortality especially due to cardiovascular diseases, and associated with various systemic complications, including hypertension, glucose intolerance or diabetes mellitus, dyslipidemia and coagulopathy. Few studies have systematically evaluated the mortality of CS in a large and worldwide population of CS. The MISSION study is a retrospective study aimed at assessing the mortality in a large ...

ea0026p73 | Endocrine tumours and neoplasia | ECE2011

68Ga-DOTATATE PET shows a better diagnostic performance than octreoscan in patients with neuroendocrine tumors

Faggiano Antongiulio , Aloi Luigi , Caraco Corradina , Ramundo Valeria , Severino Rosa , Lombardi Gaetano , Colao Annamaria , Lastoria Secondo

Background and objective: 111In-DPTA-Octreotide (Octreoscan) has limited spatial resolution and a somewhat lower receptor affinity of the radiopeptide compared to DOTATATE, a novel somatostatin analogue, which can be radiolabelled with 68Ga and adapted for PET imaging, resulting in an increased spatial resolution. The aim of this study was to evaluate the diagnostic performance of 68Ga-DOTATATE PET in patients with NET and to compare this tecni...

ea0026p75 | Endocrine tumours and neoplasia | ECE2011

T-type calcium channel blockers inhibit hormone secretion and induce apoptotic cell death in a medullary thyroid cancer cell line

Pivonello R , Pivonello C , Cavaccini A , Sarnataro M , Cariati F , Faggiano A , Colao A , Cataldi M

Medullary thyroid carcinoma (MTC) accounts for ~5–10% of thyroid cancers. Intense efforts are currently directed toward the identification of new druggable targets for the treatment of MTC. The aim of this study was to investigate whether drugs acting at voltage-gated T-type calcium channels could affect hormone release and/or cell proliferation in a MTC cell line, the TT cells. The expression of the three isoforms of T-type calcium channels (CaV3.1, CaV3.2 and CaV3.3) wa...

ea0026p226 | Pituitary | ECE2011

Tumor occurrence or recurrence after five year GH replacement theraphy

Savanelli M C , Scarano E , Brunelli V , Lombardi G , Colao A , Di Somma C

GH replacement is widely used in adults with hypopituitarism, but its effect on tumor occurrence and pituitary tumor recurrence is unknown. Furthermore, in literature there are scant with short follow-up time. The available data do not seem to suggest that rhGH replacement increased the incidence of regrowth of pituitary tumor and of cancer in adults with GHD, provided that IGF1 concentrations remain within the normal range for age.The aim of our study w...

ea0026p274 | Pituitary | ECE2011

Recent changes in clinical presentation and therapeutic approach in MEN1-related pituitary adenomas

Ramundo Valeria , Severino Rosa , Milone Francesco , Lombardi Gaetano , Colao Annamaria , Faggiano Antongiulio

Background and objective: Pituitary adenomas (PAs) affect about half of the patients with multiple endocrine neoplasia type 1 (MEN1); in the most of cases PA is a PRL-oma and generally more aggressive than the sporadic form. The aim of this study is to evaluate the recent changes in clinical presentation and therapeutic approach of MEN1-related PAs.Patients and methods: The study population included 17 patients with MEN1-related PA followed-up between 19...